Opportunity
DIBBS #SPE2DP-26-T-3650
DLA Solicitation for Gabapentin Capsules, 100 mg, 100 Count Bottles
Posted
June 04, 2026
Respond By
June 09, 2026
Identifier
SPE2DP-26-T-3650
NAICS
424210
This opportunity involves the Defense Logistics Agency Troop Support Medical Supply Chain Pharm FSA seeking Gabapentin Capsules for pharmaceutical supply needs. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - Office: Buyer Code DJM0448 - Products Requested: - Gabapentin Capsules, 100 mg, 100 count bottles - National Stock Number (NSN): 6505-01-387-1892 - Quantities: 5 bottles (CLIN 0001), 2 bottles (CLIN 0002) - OEMs (Approved Manufacturers): - Marlex Pharmaceuticals Inc (NDC10135-0644-01) - Cipla USA Inc (NDC69097-0813-07) - Sciegen Pharmaceuticals Inc (NDC50228-0179-01) - Notable Requirements: - Delivery required within 5 days from award - Packaging and marking must comply with DLA and medical standards (MIL-STD-2073-1E, Medical Marking Standard No. 1) - Shelf life: 36 months, non-extendable - Compliance with Buy American Act and hazardous material labeling - No unique requirements beyond standard federal acquisition and pharmaceutical supply protocols
Description
GABAPENTIN CAPSULES (QTY: 5, NSN: 6505-01-387-1892, Purchase Request: 7016153280) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC
GABAPENTIN CAPSULES (QTY: 2, NSN: 6505-01-387-1892, Purchase Request: 7016615962) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC